T.N. VASILKOVA¹, T.B. BAKLAEVA², S.I. MATAEV³, Yu.A. RYBINA¹

¹Tyumen State Medical Academy, 54 Odesskaya St., Tyumen, Russian Federation 625023

²Regional Hospital №19, 2а Avtoremontnaya St., Tyumen, Russian Federation 625017

³Scientific Centre of prophylactic and therapeutic nutrition of Tyumen Research Center of Siberian Branch of the Russian Academy of Medical Sciences, 71a/1 Yamskaya St., Tyumen, Russian Federation 625001

Vasilkova T. N. — D.Med.Sc., Professor of the Department of Hospital Therapy with a course of Endocrinology, tel. (3452) 42-09-00, e-mail: vasilkovatn@rambler.ru¹

Baklaeva T. B. — general physician, tel. +7-919-922-06-52, e-mail: tatyanka03@yandex.ru²

Mataev S.I. — D.Med.Sc., Professor, Director, tel. (3452) 42-09-00, e-mail: mataevci@rambler.ru³

Rybina Yu.A. — internship doctor, tel. +7-922-485-45-91, e-mail: doctorulia555@mail.ru¹

Obesity is one of the most common diseases in the world and is considered a new non-infectious «epidemy of the XXI century». It is proved that in proportion to the development of obesity grows the frequency of cardiovascular changes. The most common cause of cardiovascular complications is exactly the visceral (internal, abdominal) obesity. At the present time there are several non-invasive, affordable, safe, low-cost methods to assess the nature of fat deposition in vivo.

Key words: arterial hypertension, heart, obesity, risk, method.

 

REFERENCES

1. Kupchinskaya E.G., Voloshina O.A., Lizogub I.V. Hypertensionin obese patients. Zdorov’ya Ukraini, 2010, no. 3, pp. 36-38. (in Russ.).

2. Lloyd-Jones D., Adams R.J., Brown T.M., et al. Executive summary: Heart disease and stroke statistics-2010 update: A report from the American Heart Association. Circulation, 2010, vol. 121, no. 7, pp. e46-e215.

3. Nikolaev D.V., Smirnov A.V., Bobrinskaya I.G., et al. Bioimpedansnyy analiz sostava tela cheloveka [Bioimpedanceanalysisof human body composition]. Moscow, Nauka Publ., 2009. 392 p.

4. Montani J.P., Carroll J.F., Dwyer T.M., et al. Ectopic fat storage in heart, blood vessels and kidneys in the pathogenesis of cardiovascular diseases. International Journal of Obesity, 2004, vol. 28, Suppl. 4, pp. S58-S65.

5. Bondarenko V.M., Marchuk V.P., Pimanov S.I., Mikhaylova N.A., Makarenko E.V. Correllation between the content of visceral fatty tissue by computed tomography findings with anthropometric measurements and the results of ultrasound investigation. Vestnik Vitebskogo gosudarstvennogo meditsinskogo universiteta [Bulletin of Vitebsk State Medical University], 2013, vol. 12, no. 1, pp. 31-38. (in Russ.).

6. Otto T.C., Lane M.D. Adipose development: From stem cell to adipocyte. Critical Reviews in Biochemistry and Molecular Biology, 2005, vol. 40, no. 4, pp. 229-242. DOI: 10.1080/10409230591008189.

7. Hajer G.R., van Haeften T.W., Visseren F.L.J. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. European Heart Journal, 2008, vol. 29, no. 24, pp. 2959-2971. DOI: 10.1093/eurheartj/ehn387.

8. Chu N.F., Spiegelman D., Hotamisligil G.S., et al. Plasma insulin, leptin, and soluble TNF receptoirs levels in relation to obesity related atherogenic and thrombogenic cardiovascular disease risk factors among men. Atherosclerosis, 2001, vol. 157, no. 2, pp. 495-503. DOI: 10.1016/S0021-9150(00)00755-3.

9. Wannamethee S.G., Lowe G.D., Rumley A., et al. Adipokines and risk of type 2 diabetes in older men. Diabetes Care, 2007, vol.30, no. 5, pp. 1200-1205. DOI: 10.2337/dc06-2416.

10. Shilov A.M., Avshalumov A.S., Galanova A.S., Markovskiy V.B., Sinitsina E.N. Obesity andhypertension. Lechashchiy vrach, 2008, no. 2, pp. 8-13. (in Russ.).

11. Chichkova M.A., Kozlova O.S. The peculiarities of left ventricular remodeling in patients with essential arterial hypertension and obesity. Astrakhanskiy meditsinskiy zhurnal, 2012, vol. 7, no. 2, pp. 99-104. (in Russ.).

12. Veber V.R., Rubanova M.P., Kopina M.N., Zhmaylova S.V., Shmat’ko D.P., Prozorova I.V. Influence of abdominal obesity on heart structural and functional changes and possibility of their pharmacological correction in patients with arterial hypertension. Ratsional’naya farmakoterapiya v kardiologii, 2008, vol. 4, no. 4, pp. 28-31. (in Russ.).

13. Ovchinnikov A.G. Obesity andcardiovascular system. Serdtse, 2005, vol. 4, no. 5, pp. 243-253. (in Russ.).

14. Kovaleva O.N. Obesity problemfrom the standpoint ofcardiology. Zdorov’ya Ukraini, 2006, no. 22/1, pp. 39-40. (in Russ.).

15. He J., Ogden L.G., Bazzano L.A., et al. Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study. Archives of Internal Medicine, 2001, vol. 161, no. 7, pp. 996-1002.

16. Kenchaiah S., Evans J.C., Levy D., et al. Obesity and the risk of heart failure. New England Journal of Medicine, 2002, vol. 347, no. 5, pp. 305-313. DOI: 10.1056/NEJMoa020245.

17. Wilhelmsen L., Rosengren A., Eriksson H., Lappas G. Heart failure in the general population of men-morbidity, risk factors and prognosis. Journal of Internal Medicine, 2001, vol. 249, no. 3, pp. 253-261. DOI: 10.1046/j.1365-2796.2001.00801.x.

18. Domanski M.J., Jablonski K.A., Rice M.M., Fowler S.E., Braunwald E. Obesity and cardiovascular events in patients with established coronary disease. European Heart Journal, 2006, vol. 27, no. 12, pp. 1416-1422. DOI: 10.1093/eurheartj/ehl022.

19. Cho E., Manson J.E., Stampfer M.J., et al. A prospective study of obesity and risk of coronary heart disease among diabetic women. Diabetes Care, 2002, vol. 25, no. 7, pp. 1142-1148. DOI: 10.2337/diacare.25.7.1142.

20. Fomina I.G., Georgadze Z.O., Pokrovskaya A.E., Shepeleva E.V. Obesity effects on cardiovascular system. Kardiovaskulyarnaya terapiya i profilaktika, 2008, vol. 7, no. 2, pp. 91-97. (in Russ.).

21. Belyakova N.A., Mazurova V.I. Ozhirenie [Obesity]. St. Petersburg, SPb. Med. Acad. Postgrad. Educ. Publ.,2003. 520 p.

22. Lemieux S., Despres J., Moorjani S., et al. Are gender differences in cardiovascular disease risk factors explained by the level of visceral adipose tissue? Diabetologia, 1994, vol. 37, no. 8, pp. 757-764.

23. Wajchenberg B.L. Subcutaneous and visceral adipose tissue: Their relation to the metabolic syndrome. Endocrine Reviews, 2000, vol. 21, no. 6, pp. 697-738. DOI: 10.1210/er.21.6.697.

24. Vlachos I.S., Hatziioannou A., Perelas A., et al. Sonographic assessment of regional adiposity. AJR: American Journal of Roentgenology, 2007, vol. 189, no. 6, pp. 1545-1553. DOI: 10.2214/AJR.07.2366.

25. Zhuravleva L.V., Yankevich A.A. Ultrasonic methods of diagnosis of abdominal obesity. Ukrainskiy terapevticheskiy zhurnal, 2011, no. 3, pp. 119-121. (in Russ.).

26. Solov’eva A.V., Pronkina V.V., Rakita D.R. The diagnostic meaning of the estimation of subcutaneous and intraabdominal fat of patients with ischemic heart disease. Meditsinskiy al’manakh, 2012, no. 4, pp. 137-139. (in Russ.).

27. Kasparov E.V., Gogolashvili N. G., Prakhin E. I., Tuchkov A.A. Obesity, overweight, and cardiovascular diseases: Current approaches to preventing emergency events. Doktor.Ru, 2012, no. 10, pp. 40-42.